{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:15:11Z","timestamp":1788401711763,"version":"build-2803163510"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Pain is a prevalent discomfort symptom associated with cancer, yet the correlations and potential mechanisms between pain and the efficacy of cancer immunotherapy remain uncertain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Non-small cell lung cancer (NSCLC) patients who received immune checkpoint inhibitors (ICIs) in the inpatient department of Guangdong Provincial Hospital of Chinese Medicine from January 1, 2018, to December 31, 2021, were retrospectively enrolled. Through cox regression analysis, prognostic factors and independent prognostic factors affecting the efficacy of ICIs were identified, and a nomogram model was constructed. Hub cancer-related pain genes (CRPGs) were identified through bioinformatic analysis. Finally, the expression levels of hub CRPGs were detected using an enzyme-linked immunosorbent assay (ELISA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Before PSM, a total of 222 patients were enrolled in this study. Univariate and multivariate cox analysis indicated that bone metastasis and NRS scores were independent prognostic factors for the efficacy of ICIs. After PSM, a total of 94 people were enrolled in this study. Univariate cox analysis and multivariate cox analysis indicated that age, platelets, Dnlr, liver metastasis, bone metastasis, and NRS scores were independent prognostic factors for the efficacy of ICIs. A nomogram was constructed based on 6 independent prognostic factors with AUC values of 0.80 for 1-year, 0.73 for 2-year, and 0.80 for 3-year survival. ELISA assay results indicated that the level of CXCL12 significantly decreased compared to baseline after pain was relieved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Baseline pain is an independent prognostic factor affecting the efficacy of ICIs in lung cancer, potentially through CXCL12-mediated inflammation promotion and immunosuppression.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1456150","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T06:25:45Z","timestamp":1732515945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Unraveling impact and potential mechanisms of baseline pain on efficacy of immunotherapy in lung cancer patients: a retrospective and bioinformatic analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Zexin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaya","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/cancers15030591","article-title":"Update on prevalence of pain in patients with cancer 2022: A systematic literature review and meta-analysis","volume":"15","author":"Snijders","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.12.023","article-title":"The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients","volume":"40","author":"Kroenke","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.3390\/jcm10194469","article-title":"Coping strategies, pain, and quality of life in patients with breast cancer","volume":"10","author":"O\u015bmia\u0142owska","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0885-3924(02)00542-0","article-title":"Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients","volume":"25","author":"Lin","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0423","article-title":"Cancer pain: a review of epidemiology, clinical quality and value impact","volume":"13","author":"Neufeld","year":"2017","journal-title":"Future Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1184961","article-title":"Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-1509","article-title":"Tumor-host cometabolism collaborates to shape cancer immunity","volume":"14","author":"Wu","year":"2024","journal-title":"Cancer Discov."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00550","article-title":"The PD1:PD-L1\/2 pathway from discovery to clinical implementation","volume":"7","author":"Bardhan","year":"2016","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00934","article-title":"Five-year overall survival for patients with advanced non-Small-cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study","volume":"37","author":"Garon","year":"2019","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2187","article-title":"Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab","volume":"5","author":"Topalian","year":"2019","journal-title":"JAMA Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.956788","article-title":"The influence of baseline characteristics on the efficacy of immune checkpoint inhibitors for advanced lung cancer: A systematic review and meta-analysis","volume":"13","author":"Xiao","year":"2022","journal-title":"Front Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19990115)85:2<333::aid-cncr10>3.0.co;2-q","article-title":"Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma","volume":"85","author":"Herndon","year":"1999","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl183","article-title":"Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975","volume":"17","author":"Efficace","year":"2006","journal-title":"Ann Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"671386","DOI":"10.1155\/2012\/671386","article-title":"Effects of different electroacupuncture scheduling regimens on murine bone tumor-induced hyperalgesia: sex differences and role of inflammation","volume":"2012","author":"Smeester","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001032","article-title":"Therapeutic potential for leukocyte elastase in chronic pain states harboring a neuropathic component","volume":"158","author":"Bali","year":"2017","journal-title":"Pain"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1121515","article-title":"Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour site","volume":"51","author":"Takakura","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00946","article-title":"Concepts collide: genomic, immune, and microbial influences on the tumor microenvironment and response to cancer therapy","volume":"9","author":"Andrews","year":"2018","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","article-title":"Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies","volume":"18","author":"Cupp","year":"2020","journal-title":"BMC Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41467-021-20935-9","article-title":"Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors","volume":"12","author":"Valero","year":"2021","journal-title":"Nat Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14381","DOI":"10.1038\/ncomms14381","article-title":"Neutrophils dominate the immune cell composition in non-small cell lung cancer","volume":"8","author":"Kargl","year":"2017","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130850","article-title":"Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC","volume":"4","author":"Kargl","year":"2019","journal-title":"JCI Insight"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/JP9.0000000000000140","article-title":"Pancreatic cancer-related pain: mechanism and management","volume":"6","author":"Wu","year":"2023","journal-title":"J Pancreatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05374-w","article-title":"Nociceptor neurons affect cancer immunosurveillance","volume":"611","author":"Balood","year":"2022","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"111647","DOI":"10.1016\/j.celrep.2022.111647","article-title":"Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8(+) T cell exhaustion and curtails anti-PD-1 efficacy","volume":"41","author":"Chen","year":"2022","journal-title":"Cell Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-3556","article-title":"Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma","volume":"77","author":"Prat","year":"2017","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/j.pain.0000000000001363","article-title":"The IASP classification of chronic pain for ICD-11: chronic cancer-related pain","volume":"160","author":"Bennett","year":"2019","journal-title":"Pain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00228-019-02801-2","article-title":"The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European palliative care Cancer symptom study","volume":"76","author":"Boland","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00520-022-07557-7","article-title":"Feasibility and pilot testing of a personalized eHealth intervention for pain science education and self-management for breast cancer survivors with persistent pain: a mixed-method study","volume":"31","author":"De Groef","year":"2023","journal-title":"Support Care Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-23-375","article-title":"Effect of baseline cancer pain on the efficacy of immunotherapy in lung cancer patients","volume":"15","author":"Zhou","year":"2023","journal-title":"J Thorac Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj7152","article-title":"Immune regulation of pain: Friend and foe","volume":"13","author":"Kavelaars","year":"2021","journal-title":"Sci Transl Med."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat Neurosci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0769-3","article-title":"The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat Immunol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1994","article-title":"Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000124","article-title":"Tumor stroma, tumor blood vessels, and antiangiogenesis therapy","volume":"21","author":"Dvorak","year":"2015","journal-title":"Cancer J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abm5505","article-title":"Innate immunological pathways in COVID-19 pathogenesis","volume":"7","author":"Paludan","year":"2022","journal-title":"Sci Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"107233","DOI":"10.1016\/j.intimp.2020.107233","article-title":"Neutrophils and COVID-19: The road so far","volume":"90","author":"Cavalcante-Silva","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/gep053","article-title":"Genotoxic effects of neutrophils and hypochlorous acid","volume":"25","author":"G\u00fcng\u00f6r","year":"2010","journal-title":"Mutagenesis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v125:4","article-title":"IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer","volume":"125","author":"Rotondo","year":"2009","journal-title":"Int J Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804261","article-title":"Human embryonic stem cells suppress T cell responses via arginase I-dependent mechanism","volume":"184","author":"Yachimovich-Cohen","year":"2010","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Bambace","year":"2011","journal-title":"J Thromb Haemost"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.139.7.2406","article-title":"Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system","volume":"139","author":"el-Hag","year":"1987","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-bioeng-061008-124949","article-title":"Cancer cells in transit: the vascular interactions of tumor cells","volume":"11","author":"Konstantopoulos","year":"2009","journal-title":"Annu Rev BioMed Eng"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2272","article-title":"Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells","volume":"105","author":"Palumbo","year":"2005","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-4010","article-title":"Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells","volume":"72","author":"Coupland","year":"2012","journal-title":"Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2001.tb01063.x","article-title":"Identification and characterisation of a platelet GPIb\/V\/IX-like complex on human breast cancers: implications for the metastatic process","volume":"92","author":"Suter","year":"2001","journal-title":"Jpn J Cancer Res"},{"key":"B52","article-title":"Multiple roles for platelet GPIIb\/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis","volume":"62","author":"Trikha","year":"2002","journal-title":"Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.v234.6","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: A review","volume":"234","author":"Farhood","year":"2019","journal-title":"J Cell Physiol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01035-y","article-title":"Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta\u2212analysis","volume":"23","author":"Kou","year":"2023","journal-title":"Clin Exp Med."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.3390\/ijms23126832","article-title":"Bone metastasis and immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): microenvironment and possible clinical implications","volume":"23","author":"Del Conte","year":"2022"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2011.47","article-title":"Bone marrow and the control of immunity","volume":"9","author":"Zhao","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12264-015-0007-4","article-title":"Upregulation of chemokine CXCL12 in the dorsal root ganglia and spinal cord contributes to the development and maintenance of neuropathic pain following spared nerve injury in rats","volume":"32","author":"Bai","year":"2016","journal-title":"Neurosci Bull"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1172\/JCI92117","article-title":"Reducing CXCR4-mediated nociceptor hyperexcitability reverses painful diabetic neuropathy","volume":"128","author":"Jayaraj","year":"2018","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000805","article-title":"Epigenetic upregulation of CXCL12 expression mediates antitubulin chemotherapeutics-induced neuropathic pain","volume":"158","author":"Xu","year":"2017","journal-title":"Pain"},{"key":"B62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1742-2094-11-75","article-title":"CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord","volume":"11","author":"Shen","year":"2014","journal-title":"J Neuroinflamm"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.465.65.2","article-title":"CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers","volume":"65","author":"Kryczek","year":"2005","journal-title":"Cancer Res"},{"key":"B64","article-title":"Epithelial cancer cell migration: a role for chemokine receptors","volume":"61","author":"Scotton","year":"2001","journal-title":"Cancer Res"},{"key":"B65","article-title":"Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer","volume":"62","author":"Scotton","year":"2002","journal-title":"Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nri3049","article-title":"Homeostatic chemokine receptors and organ-specific metastasis","volume":"11","author":"Zlotnik","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0909602","article-title":"The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease","volume":"88","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080730","article-title":"CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells","volume":"205","author":"Meiron","year":"2008","journal-title":"J Exp Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuron.2010.12.006","article-title":"Cxcr7 controls neuronal migration by regulating chemokine responsiveness","volume":"69","author":"S\u00e1nchez-Alca\u00f1iz","year":"2011","journal-title":"Neuron"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.5.2902","article-title":"Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1\/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control","volume":"176","author":"Vianello","year":"2006","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/75022","article-title":"Active movement of T cells away from a chemokine","volume":"6","author":"Poznansky","year":"2000","journal-title":"Nat Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-005-0675-z","article-title":"Fugetaxis: active movement of leukocytes away from a chemokinetic agent","volume":"83","author":"Vianello","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119463119","article-title":"Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack","volume":"119","author":"Wang","year":"2022"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1101133108","article-title":"Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways","volume":"108","author":"Drury","year":"2011","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01443-y","article-title":"T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control","volume":"24","author":"Steele","year":"2023","journal-title":"Nat Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1456150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T06:25:49Z","timestamp":1732515949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1456150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2024.1456150"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1456150","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"article-number":"1456150"}}